
Brian E. Mcdowell
Examiner (ID: 17098, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1657 |
| Issued Applications | 1038 |
| Pending Applications | 129 |
| Abandoned Applications | 533 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5279533
[patent_doc_number] => 20090131665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Process for the preparation of crystalline forms A, B and pure crystalline form a of erlotinib HCI'
[patent_app_type] => utility
[patent_app_number] => 12/229701
[patent_app_country] => US
[patent_app_date] => 2008-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6766
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131665.pdf
[firstpage_image] =>[orig_patent_app_number] => 12229701
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/229701 | Process for the preparation of crystalline forms A, B and pure crystalline form a of erlotinib HCI | Aug 24, 2008 | Abandoned |
Array
(
[id] => 5324267
[patent_doc_number] => 20090062257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED VARENICLINE'
[patent_app_type] => utility
[patent_app_number] => 12/198054
[patent_app_country] => US
[patent_app_date] => 2008-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3129
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062257.pdf
[firstpage_image] =>[orig_patent_app_number] => 12198054
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/198054 | DEUTERIUM-ENRICHED VARENICLINE | Aug 24, 2008 | Abandoned |
Array
(
[id] => 5272266
[patent_doc_number] => 20090076042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED ERLOTINIB'
[patent_app_type] => utility
[patent_app_number] => 12/196369
[patent_app_country] => US
[patent_app_date] => 2008-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3639
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076042.pdf
[firstpage_image] =>[orig_patent_app_number] => 12196369
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/196369 | DEUTERIUM-ENRICHED ERLOTINIB | Aug 21, 2008 | Abandoned |
Array
(
[id] => 5324377
[patent_doc_number] => 20090062367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED ELETRIPTAN'
[patent_app_type] => utility
[patent_app_number] => 12/195581
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4773
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062367.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195581
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195581 | DEUTERIUM-ENRICHED ELETRIPTAN | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5324313
[patent_doc_number] => 20090062303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED ZIPRASIDONE'
[patent_app_type] => utility
[patent_app_number] => 12/195826
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5142
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062303.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195826
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195826 | DEUTERIUM-ENRICHED ZIPRASIDONE | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5272255
[patent_doc_number] => 20090076031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED BORTEZOMIB'
[patent_app_type] => utility
[patent_app_number] => 12/196216
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3364
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076031.pdf
[firstpage_image] =>[orig_patent_app_number] => 12196216
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/196216 | DEUTERIUM-ENRICHED BORTEZOMIB | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5324333
[patent_doc_number] => 20090062323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED IRINOTECAN'
[patent_app_type] => utility
[patent_app_number] => 12/195936
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3524
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062323.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195936
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195936 | DEUTERIUM-ENRICHED IRINOTECAN | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5324367
[patent_doc_number] => 20090062357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED FLUCONAZOLE'
[patent_app_type] => utility
[patent_app_number] => 12/195956
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3638
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062357.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195956
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195956 | DEUTERIUM-ENRICHED FLUCONAZOLE | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5324378
[patent_doc_number] => 20090062368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED SUNITINIB'
[patent_app_type] => utility
[patent_app_number] => 12/195881
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4531
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062368.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195881
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195881 | DEUTERIUM-ENRICHED SUNITINIB | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5272267
[patent_doc_number] => 20090076043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED ALFUZOSIN'
[patent_app_type] => utility
[patent_app_number] => 12/196198
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3664
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076043.pdf
[firstpage_image] =>[orig_patent_app_number] => 12196198
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/196198 | DEUTERIUM-ENRICHED ALFUZOSIN | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5410703
[patent_doc_number] => 20090124602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/187909
[patent_app_country] => US
[patent_app_date] => 2008-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81107
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20090124602.pdf
[firstpage_image] =>[orig_patent_app_number] => 12187909
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/187909 | Amino substituted pyridines as potent kinase inhibitors | Aug 6, 2008 | Issued |
Array
(
[id] => 9455466
[patent_doc_number] => 08716476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-06
[patent_title] => 'Process for the preparation of alfuzosin hydrochloride'
[patent_app_type] => utility
[patent_app_number] => 12/671418
[patent_app_country] => US
[patent_app_date] => 2008-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5890
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671418
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671418 | Process for the preparation of alfuzosin hydrochloride | Jul 31, 2008 | Issued |
Array
(
[id] => 7778549
[patent_doc_number] => 20120040997
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2012-02-16
[patent_title] => 'VINYL-ARYL DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES'
[patent_app_type] => utility
[patent_app_number] => 12/452980
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26693
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0040/20120040997.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452980
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452980 | Vinyl-aryl derivatives for inflammation and immune-related uses | Jul 30, 2008 | Issued |
Array
(
[id] => 6320931
[patent_doc_number] => 20100196460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'Integrated Photoactive Agents for Real-Time Monitoring of Hemostasis'
[patent_app_type] => utility
[patent_app_number] => 12/669497
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7186
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196460.pdf
[firstpage_image] =>[orig_patent_app_number] => 12669497
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/669497 | Integrated photoactive agents for real-time monitoring of hemostasis | Jul 30, 2008 | Issued |
Array
(
[id] => 6466382
[patent_doc_number] => 20100190779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'VIRAL POLYMERASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/671780
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27730
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20100190779.pdf
[firstpage_image] =>[orig_patent_app_number] => 12671780
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671780 | Viral polymerase inhibitors | Jul 30, 2008 | Issued |
Array
(
[id] => 7778549
[patent_doc_number] => 20120040997
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2012-02-16
[patent_title] => 'VINYL-ARYL DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES'
[patent_app_type] => utility
[patent_app_number] => 12/452980
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26693
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0040/20120040997.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452980
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452980 | Vinyl-aryl derivatives for inflammation and immune-related uses | Jul 30, 2008 | Issued |
Array
(
[id] => 6595237
[patent_doc_number] => 20100130740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'PROCESS FOR PREPARATION OF RISPERIDONE'
[patent_app_type] => utility
[patent_app_number] => 12/452874
[patent_app_country] => US
[patent_app_date] => 2008-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3085
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130740.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452874
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452874 | PROCESS FOR PREPARATION OF RISPERIDONE | Jul 24, 2008 | Abandoned |
Array
(
[id] => 7988369
[patent_doc_number] => 08076480
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-13
[patent_title] => 'Process of preparing optically active allyl compound'
[patent_app_type] => utility
[patent_app_number] => 12/179069
[patent_app_country] => US
[patent_app_date] => 2008-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4044
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/076/08076480.pdf
[firstpage_image] =>[orig_patent_app_number] => 12179069
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/179069 | Process of preparing optically active allyl compound | Jul 23, 2008 | Issued |
Array
(
[id] => 7545598
[patent_doc_number] => 08053570
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-08
[patent_title] => 'Method for producing α-form titanylphthalocyanine and electrophotographic photoreceptor comprising α-form titanylphthalocyanine'
[patent_app_type] => utility
[patent_app_number] => 12/177738
[patent_app_country] => US
[patent_app_date] => 2008-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 7742
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/053/08053570.pdf
[firstpage_image] =>[orig_patent_app_number] => 12177738
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/177738 | Method for producing α-form titanylphthalocyanine and electrophotographic photoreceptor comprising α-form titanylphthalocyanine | Jul 21, 2008 | Issued |
Array
(
[id] => 9662544
[patent_doc_number] => 08809523
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-19
[patent_title] => 'Method of making nanosized particles of phthalocyanine pigments'
[patent_app_type] => utility
[patent_app_number] => 12/177727
[patent_app_country] => US
[patent_app_date] => 2008-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11135
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12177727
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/177727 | Method of making nanosized particles of phthalocyanine pigments | Jul 21, 2008 | Issued |